In contrast to Notch1 and 4, our previous study (Dou et al., 2017) showed that Notch3 was mainly expressed in luminal breast cancer cells but not in either basal-like or HER2 (human epidermal growth factor receptor 2)-positive breast cancer cell line. Here, NOTCH3 is linked to breast carcinoma.